- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The burden of diagnosed Crohn’s disease (CD) is expected to grow between 2016 and 2026 in the seven major markets (7MM) *. Epidemiologists from GlobalData, a leading data and analysis company, forecast an increase in the number of diagnosed incident cases, most notably in the US and Japan. The chart below presents the expected changes in the 7MM from 2016 to 2026.
The pet insurance market broke the £1bn mark in gross written premiums for the first time in 2016
The UK pet insurance market has continued to see significant growth, with gross written premiums (GWP) increasing by 7.1% to £1,045m in 2016, according to GlobalData, a recognized leader in providing business information and analytics.
Taiwan’s Pharmaceutical Market Value to Reach $2.44 billion in 2021
The pharmaceutical market in Taiwan is estimated to reach $2.44 billion in 2021, according to GlobalData, a recognized leader in providing business information and analytics.
Indonesian Pharmaceutical Market Value to Reach $10.11 billion by 2021
Indonesia’s pharmaceutical market is the largest market in the Association of Southeast Nations (ASEAN) and is expected to reach $10.11 billion by 2021, according to GlobalData, a recognized leader in providing business information and analytics.
Crohn’s disease market growth to 2026 fuelled by interleukin inhibitor and anti-integrin therapy launches
The global Crohn’s disease (CD) market valued at $9.2 billion in 2016 is set to reach $13.4 billion by 2026, a Compound Annual Growth Rate (CAGR) of 3.8%, across the * 7MM according to GlobalData, a recognized leader in providing business information and analytics.
Alzheimer’s disease market set for double-digit growth with forecast sales of $14.8Bn by 2026
The global Alzheimer’s Disease (AD) market worth $2.9Bn in 2016 is set to reach $14.8Bn, rising at a Compound Annual Growth Rate (CAGR) of 17.5%, across the * 7MM by 2026 according to GlobalData, a recognized leader in providing business information and analytics.
Online event to reveal six packaging innovations making waves for FMCG Brands
With the recent announcement by the Scottish Government of plans to introduce a deposit on return scheme for plastic bottles and cans and a number of the high profile environmental campaigns highlighting the issue of plastic packaging waste, packaging of all kinds have gained a high profile in the news and become a very topical subject over the last 12 months.
Global migraine market set to be worth $8.7 Billion by 2026
Global migraine sales are expected to grow to $8.7 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 10.3% across the seven major markets * 7MM, according to GlobalData, a recognized leader in providing business information and analytics. The US will continue to dominate the market with a 77% share of total sales by 2026 followed by Germany (5.6%) and Italy (5.2%).
Healthcare-Associated Gram-Negative market to be worth $3.6 billion by 2026
The global marketplace for healthcare-associated infections (HAIs) caused by Gram-negative bacteria across the seven major pharmaceutical markets * (7MM) is projected to exceed $3.6 billion in sales by 2026, at a Compound Annual Growth Rate (CAGR) of 10.8% from 2016–2026, according to GlobalData, a recognized leader in providing business information and analytics.
Solar eclipses all other new types of electricity generation in 2016 to become the world’s favourite
Solar has become the world’s favorite new type of electricity generation, with more solar photovoltaic (PV) capacity being installed than any other generation technology according to GlobalData, a recognized leader in providing business information and analytics.
Clothing & footwear to drive UK E-retail spend to £68.8 billion by 2022
The UK E-retail market is forecast to rise 35% over the next five years reaching £68.8 billion by 2022, according to GlobalData, a recognized leader in providing business information and analytics.
Immuno-Oncology (IO) looks set to become the fifth pillar of cancer treatment
Immuno-Oncology (IO) looks set to become the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and other targeted treatments according to GlobalData, a recognized leader in providing business information and analytics.
Athleisure is here to stay as ASOS targets lucrative £2.5bn UK sports clothing market
The athleisure trend will reach new heights this year, pushing the UK sports clothing market to £2.5 billion in 2017, up 8% on 2016, according to GlobalData, a recognized leader in providing business information and analytics.
Type 2 diabetes market to more than double, to $64 billion by 2026
The type 2 diabetes space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to more than double in value from $26.8 billion in 2016 to around $64 billion by 2026. While the global T2D market is crowded with inexpensive generics and marked by a late-stage pipeline filled with me-too drugs, the market is expected to grow at a strong compound annual growth rate of 8.4%, according to research and consulting firm GlobalData.
UK consumers to face 3% year-on-year food price rises until 2022
Inflation across all food and grocery categories in the UK has well and truly set in, with consumers forced to pay more for their daily essentials and treats, boosting annual spend per head by £55 to £2,686 in 2017, according to GlobalData, a recognized leader in providing business information and analytics.
Global HER2-positive breast cancer market to face challenges from biosimilars through to 2025
The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer space across the eight major markets of the US, France, Germany, Italy, Spain, the UK, Japan, and China, which is set to hit $9.89 billion in 2025, is likely to face barriers due to the introduction of new biosimilars, according to GlobalData, a recognized leader in providing business information and analytics.
Nephrology and Urology Devices market growth predictions drive $57 billion investment
The latest report on the Nephrology and Urology Devices market from GlobalData, a recognized leader in providing business information and analytics, has highlighted how an explosion in diabetes and hypertension combined with aging populations is driving investment to meet patient needs. Leading companies in this field, principally from Europe and North America, have invested over $42 billion in mergers and acquisitions and nearly $15 billion in capital raisings over the last 3 years.
WEBINAR: Key Ingredient Trends in FMCG – What Consumers are Saying in 2017
Primary research results from GlobalData, a recognized leader in providing business information and analytics, have revealed that the presence of natural ingredients would make 46% of consumers globally choose one brand over another when shopping.
Global Clostridium difficile infections market to approach $1.7 billion by 2026
The Clostridium difficile infections (CDIs) space across the seven major markets of the US, France, Germany, Italy, Spain, the UK and Japan, is set to grow from just under $630 million in 2016 to almost $1.7 billion by 2026, representing a compound annual growth rate of 10.2%, according to GlobalData, a recognized leader in providing business information and analytics.
Hemophilia A and B market to welcome newcomers as established companies fall behind
The hemophilia A and B market, which is set to approach $8 billion by 2026, will see a substantial number of newcomers capture market share from established companies, according to GlobalData, a recognized leader in providing business information and analytics.